This inventor holds 13 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Korea Research Institute of Bioscience and Biotechnology, Korea Institute of Science and Technology, Healthbiome. Active years: 2000-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taejeon-si, KR (2011 - 2012)
- Daejeon, KR (2000 - 2023)
Company Filing History:
8 out of 334 
4 out of 2,250 
1 out of 2 
Years Active: 2000-2026
Title: Innovations and Contributions of Inventor Chul-Ho Lee
Introduction
Chul-Ho Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of biotechnology and medicine, holding a total of 12 patents. His work focuses on developing innovative solutions for degenerative brain diseases and metabolic disorders.
Latest Patents
One of Chul-Ho Lee's latest patents involves a specific strain that has prophylactic or therapeutic effects on degenerative brain diseases. This strain, known as SR79, has shown potential in inhibiting neuroinflammation and improving cognitive and memory functions in animal models suffering from conditions such as Parkinson's disease and Alzheimer's disease. The applications of this strain extend to foods, medicines, and feeds aimed at preventing or treating these brain diseases. Another notable patent is a method for treating metabolic disorders using benzazole derivatives as active ingredients. This composition is designed to prevent and treat metabolic diseases, including obesity and diabetes, by effectively controlling lipid and energy metabolism.
Career Highlights
Chul-Ho Lee has worked with esteemed institutions such as the Korea Research Institute of Bioscience and Biotechnology and the Korea Institute of Science and Technology. His research and innovations have significantly impacted the relevant industries, particularly in health and medicine.
Collaborations
Throughout his career, Chul-Ho Lee has collaborated with notable colleagues, including Song-Hae Bok and Tae-Sook Jeong. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Chul-Ho Lee's innovative work in biotechnology and medicine has led to significant advancements in the treatment of degenerative brain diseases and metabolic disorders. His contributions continue to influence the relevant fields and improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile